Abstract
While a gene family by definition will have homologies in sequence, the “functional genomics” or characterization of the functionality of siblings can reveal significant differences. One gene family that shares an ATPbinding cassette (ABC) sequence motif is comprised of members named “ABC Transporters.” Until 1989, the members of this family were primarily ATPases that pumped compounds out of cells and many were linked to multidrug resistance (MDR). Hence, at that time the function of the members of the ABC gene family appeared equally homologous to their structure. Since then the discovery of new members, like the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel and the sulfonylurea receptor (SUR), increased diversity and the homologous structure seemed to no longer link to homologous function. In this mini-review we will introduce two parallel investigations, separated by 10 years, where researchers re-examined the functionality of the human ABC transporters, CFTR and MDR, under the hypothesis that the structurally similar ABC transporters must have similarities in function.
Keywords: multidrug, cftr, mdr, abc transporter, cystic fibrosis transmembrane conductance-receptor, sulfonylurea receptor
Current Genomics
Title: CFTR and MDR: ABC Transporters with Homologous Structure but Divergent Function
Volume: 4 Issue: 3
Author(s): Douglas B. Luckie, John H. Wilterding, Marija Krha and Mauri E. Krouse
Affiliation:
Keywords: multidrug, cftr, mdr, abc transporter, cystic fibrosis transmembrane conductance-receptor, sulfonylurea receptor
Abstract: While a gene family by definition will have homologies in sequence, the “functional genomics” or characterization of the functionality of siblings can reveal significant differences. One gene family that shares an ATPbinding cassette (ABC) sequence motif is comprised of members named “ABC Transporters.” Until 1989, the members of this family were primarily ATPases that pumped compounds out of cells and many were linked to multidrug resistance (MDR). Hence, at that time the function of the members of the ABC gene family appeared equally homologous to their structure. Since then the discovery of new members, like the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel and the sulfonylurea receptor (SUR), increased diversity and the homologous structure seemed to no longer link to homologous function. In this mini-review we will introduce two parallel investigations, separated by 10 years, where researchers re-examined the functionality of the human ABC transporters, CFTR and MDR, under the hypothesis that the structurally similar ABC transporters must have similarities in function.
Export Options
About this article
Cite this article as:
Luckie B. Douglas, Wilterding H. John, Krha Marija and Krouse E. Mauri, CFTR and MDR: ABC Transporters with Homologous Structure but Divergent Function, Current Genomics 2003; 4 (3) . https://dx.doi.org/10.2174/1389202033490394
DOI https://dx.doi.org/10.2174/1389202033490394 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Improving Safety of Gene Therapy
Current Drug Safety Epigenetic Regulation and Therapeutic Approaches in Cancer
Current Topics in Medicinal Chemistry Sumoylation in Cellular Senescence and Aging
Current Molecular Medicine Carotenoids as Modulators of Intracellular Signaling Pathways
Current Signal Transduction Therapy Drug-Induced Hypokalaemia
Current Drug Safety Immune Dysfunction in Chronic Lymphocytic Leukemia: The Role for Immunotherapy
Current Pharmaceutical Design Thrombotic Microangiopathy and Occult Neoplasia
Cardiovascular & Hematological Disorders-Drug Targets Is Going for Cure in CML Targeting Aberrant Glycogen Synthase Kinase 3β?
Current Drug Targets Therapeutic Potential of Adipose-derived Stem Cells in the Treatment of Pulmonary Diseases
Current Stem Cell Research & Therapy Limiting Functional Deficiency Following Stroke: Exploiting Different Stem Cell Reservoirs
Current Neuropharmacology Clinical Pharmacogenetics of Methotrexate
Current Drug Metabolism Glucocorticoid Receptors and Bone
Current Pharmaceutical Design PLK1 Inhibition: Prospective Role for the Treatment of Pediatric Tumors
Current Drug Targets The Function and Regulation of BMP6 in Various Kinds of Stem Cells
Current Pharmaceutical Design Molecular and Cellular Pathways as Treatment Targets for Biologic Therapies in Systemic Sclerosis
Current Medicinal Chemistry New Medical Strategies for Midgut Carcinoids
Anti-Cancer Agents in Medicinal Chemistry The Mutator Phenotype in Cancer: Molecular Mechanisms and Targeting Strategies
Current Drug Targets Low-Dose Methotrexate (LD-MTX) in Rheumatology Practice - A Most Widely Misunderstood Drug
Current Rheumatology Reviews DNA Topoisomerase II Enzymes as Molecular Targets for Cancer Chemotherapy
Current Cancer Drug Targets Radiation Protection of the Child from Diagnostic Imaging
Current Pediatric Reviews